ID24184A - Obat untuk perawatan disfungsi ereksi - Google Patents

Obat untuk perawatan disfungsi ereksi

Info

Publication number
ID24184A
ID24184A IDW20000221A ID20000221A ID24184A ID 24184 A ID24184 A ID 24184A ID W20000221 A IDW20000221 A ID W20000221A ID 20000221 A ID20000221 A ID 20000221A ID 24184 A ID24184 A ID 24184A
Authority
ID
Indonesia
Prior art keywords
medicine
disfunctions
effective
treatment
combination
Prior art date
Application number
IDW20000221A
Other languages
English (en)
Indonesian (id)
Inventor
Philippe Gorni
Original Assignee
Real 200 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Real 200 Ltd filed Critical Real 200 Ltd
Publication of ID24184A publication Critical patent/ID24184A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20000221A 1997-07-04 1998-07-06 Obat untuk perawatan disfungsi ereksi ID24184A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9708504A FR2765483B1 (fr) 1997-07-04 1997-07-04 Medicament destine a traiter les dysfonctions erectiles

Publications (1)

Publication Number Publication Date
ID24184A true ID24184A (id) 2000-07-13

Family

ID=9508874

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000221A ID24184A (id) 1997-07-04 1998-07-06 Obat untuk perawatan disfungsi ereksi

Country Status (17)

Country Link
US (1) US20020155136A1 (de)
EP (1) EP1001775B1 (de)
JP (1) JP2002511875A (de)
KR (1) KR20010021505A (de)
CN (1) CN1261798A (de)
AT (1) ATE212841T1 (de)
AU (1) AU743825B2 (de)
BR (1) BR9810981A (de)
CA (1) CA2295916A1 (de)
DE (1) DE69803773T2 (de)
DK (1) DK1001775T3 (de)
ES (1) ES2172171T3 (de)
FR (1) FR2765483B1 (de)
ID (1) ID24184A (de)
IL (1) IL133443A0 (de)
PT (1) PT1001775E (de)
WO (1) WO1999001132A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US6323211B1 (en) * 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
DE19831263A1 (de) 1998-07-11 2000-01-13 Lohmann Therapie Syst Lts Darreichungsform
EP1889614A3 (de) 1999-09-03 2010-09-22 APBI Holdings, LLC Verfahren zur Verwendung selektiver Serotonin-Wiederaufnahmehemmer mit schnellem Wirkungseintritt zur Behandlung sexueller Dysfunktionen
ES2235415T3 (es) * 1999-09-21 2005-07-01 Enzo Leone Composiciones antivirales que comprenden yohimbina como principio activo.
WO2001089543A2 (en) * 2000-05-26 2001-11-29 Horphag Research Limited Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
ITMI20020990A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
ITMI20020994A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
HUP0401422A2 (en) 2004-07-15 2006-04-28 G Laszlo Meszaros Use of l-arginine as vasoaktive ingredient absorbing through skin for external application
DE102005053241A1 (de) * 2005-11-08 2007-05-16 Schwabe Willmar Gmbh & Co Extrakte aus der Rinde von Corynanthe-Arten und deren Verwendung sowie diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen
CN111840508A (zh) * 2020-07-17 2020-10-30 北京清大赛尔生物科技有限公司 一种预防及治疗男性性功能障碍的外用制剂及其应用
CN113116905A (zh) * 2021-04-20 2021-07-16 北京天玺宝科技有限公司 一种增强男性性功能并持续改善性功能障碍的组合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response

Also Published As

Publication number Publication date
AU8446798A (en) 1999-01-25
IL133443A0 (en) 2001-04-30
EP1001775A1 (de) 2000-05-24
FR2765483B1 (fr) 2000-02-04
DK1001775T3 (da) 2002-04-29
US20020155136A1 (en) 2002-10-24
WO1999001132A1 (fr) 1999-01-14
DE69803773T2 (de) 2002-08-29
DE69803773D1 (de) 2002-03-21
KR20010021505A (ko) 2001-03-15
ATE212841T1 (de) 2002-02-15
FR2765483A1 (fr) 1999-01-08
PT1001775E (pt) 2002-07-31
CA2295916A1 (en) 1999-01-14
CN1261798A (zh) 2000-08-02
AU743825B2 (en) 2002-02-07
BR9810981A (pt) 2000-08-15
JP2002511875A (ja) 2002-04-16
ES2172171T3 (es) 2002-09-16
EP1001775B1 (de) 2002-02-06

Similar Documents

Publication Publication Date Title
ID24184A (id) Obat untuk perawatan disfungsi ereksi
FI972205A0 (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
MX9504415A (es) Eteres antivirales de isoesteres de sustrato de proteasa de aspartato.
PT1010688E (pt) 2-fenil-1-(3,4-di-hidroxi-5-nitrofenil)-1-etanonas substituidas seu uso no tratamento de algumas perturbacoes do sistema nervoso central e periferico e formulacoes do sistema nervoso central e periferico e formulacoes farmaceuticas que as contem
ES2141208T3 (es) Utilizacion de una cantidad eficaz de sustancias activas para el tratamiento de pieles mixtas.
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
DE69932510D1 (de) Vaskularisierungsinhibitoren
MY138883A (en) Use of asiatic acid for treatment of cencer
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
SE9701161D0 (sv) New use I
DE69310528D1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
BR9808221A (pt) Método de tratamento de tumor.
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
EP1037918A4 (de) Verfahren und zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
CY1106702T1 (el) Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
GB9505082D0 (en) Medicament
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
ATE200026T1 (de) Behandlung von laminitis
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
BR9708037A (pt) Método para o tratamento de abuso de substância
OA09771A (en) Asphodelus composition for increasing white blood cell count.
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome